Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines.

Abdel-Moneim, Ahmed S; Abdelwhab, Elsayed M; Memish, Ziad A

Abdel-Moneim, Ahmed S; Abdelwhab, Elsayed M; Memish, Ziad A.

Afiliação

Abdel-Moneim AS; Microbiology Department, Virology Division, College of Medicine, Taif University, Al-Taif, Saudi Arabia. Electronic address: asa@tu.edu.sa.
Abdelwhab EM; Institute of Molecular Virology and Cell Biology, Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health, Greifswald-Insel Riems, Germany.
Memish ZA; Research & Innovation Center, King Saud Medical City, Ministry of Health and College of Medicine, Alfaisal University, Riyadh, Saudi Arabia; Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.

Virology ; 558: 1-12, 2021 06.

Article em En | MEDLINE | ID: mdl-33691216

Assuntos

Antivirais/uso terapêutico; Vacinas contra COVID-19/uso terapêutico; COVID-19; SARS-CoV-2; Zoonoses Virais; Animais; COVID-19/imunologia; COVID-19/terapia; COVID-19/virologia; Humanos; Imunoterapia; SARS-CoV-2/classificação; SARS-CoV-2/efeitos dos fármacos; Zoonoses Virais/epidemiologia; Zoonoses Virais/terapia; Virulência

Palavras-chave

2019-nCoV; Bats; Betacoronaviruses; COVID-19; COVID-19 antivirals; COVID-19 vaccine; Coronavirus disease; Interspecies transmission; Viral zoonosis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Vacinas contra COVID-19 / Zoonoses Virais / SARS-CoV-2 / COVID-19 Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google